Drug Shortage Report for PAXLOVID
Report ID | 238109 |
Drug Identification Number | 02527804 |
Brand name | PAXLOVID |
Common or Proper name | PAXLOVID |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | NIRMATRELVIR RITONAVIR |
Strength(s) | 150MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 20 tablets/5 blisters |
ATC code | J05AE |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-09-20 |
Estimated end date | 2024-11-01 |
Actual end date | 2024-10-28 |
Shortage status | Resolved |
Updated date | 2024-10-29 |
Company comments | Other presentation available, ordering restrictions may apply: Paxlovid regular dose pack 30 tablets/5 blisters (DIN 02524031) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-10-29 | English | Compare |
v7 | 2024-10-28 | French | Compare |
v6 | 2024-10-28 | English | Compare |
v5 | 2024-10-07 | French | Compare |
v4 | 2024-10-07 | English | Compare |
v3 | 2024-09-21 | English | Compare |
v2 | 2024-09-20 | French | Compare |
v1 | 2024-09-20 | English | Compare |
Showing 1 to 8 of 8